| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19.9B | $17.4B | $13.6B | $9.6B | $9.2B | $6.9B | $5.5B | $5.6B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $4.4B | $4.3B | $4.4B | $1.5B | $2.2B | $1.6B | $0.8B | $0.6B |
| EPS (Basic) | $11.83 | $11.47 | $11.94 | $3.90 | $5.34 | $0.78 | $0.31 | $1.50 |
| EPS (Diluted) | $11.60 | $11.19 | $11.62 | $3.80 | $5.23 | $0.76 | $0.31 | $1.46 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $79.2B | $70.9B | $58.9B | $48.0B | $45.1B | $37.9B | $32.2B | $32.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.0B | $1.0B | $0.9B | $0.9B | $0.9B | $0.7B | $0.6B | $0.6B |
| Total Liabilities | $55.0B | $50.1B | $40.6B | $35.1B | $31.5B | $25.6B | $21.8B | $21.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $24.2B | $20.8B | $18.4B | $12.9B | $13.5B | $11.5B | $9.4B | $9.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6.2B | $6.7B | $5.7B | $3.8B | $3.4B | $2.0B | — | — |
| Investing Cash Flow | $-4.0B | $-4.5B | $-5.5B | $-3.1B | $-2.1B | $-1.8B | — | — |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.9B | $-1.9B | $-0.1B | $-0.7B | $-1.2B | $-0.1B | — | — |